4.7 Article

In vivo effects of single or combined topical neuroprotective and regenerative agents on degeneration of retinal ganglion cells in rat optic nerve crush model

期刊

SCIENTIFIC REPORTS
卷 9, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-018-36473-2

关键词

-

资金

  1. Ministry of Education, Science, Sports and Culture of the Japanese Government

向作者/读者索取更多资源

To determine the effectiveness of a single or a combination of topical neurotrophic factors (NFs) in protecting retinal ganglion cells (RGCs) in the rat optic nerve crush (ONC) model, the left ONC was performed to induce the death of the RGCs in adult Sprague-Dawley rats. The NFs studied were tauroursodeoxycholic acid (TUDCA), citicoline, neurotrophin-4 (NT-4), combined TUDCA/citicoline (Doublet-1), combined TUDCA/NT-4 (Doublet-2), combined TUDCA/citicoline/NT-4 (Triplet), and PBS. After 2 weeks, the number of RGCs was determined by Brn3a immunostaining. The optic nerves were immunostained for anti-Growth Associated Protein-43(GAP-43) and -200kD neurofilament heavy antibody to study optic nerve regeneration. Two weeks after the ONC, the densities of RGCs in all treated eyes were significantly higher than that of the PBS treated eyes. In the Triplet group, the number of RGC axons after ONC was significantly higher than that in all of the single treatment groups and the number of TUNEL positive cells was significantly reduced and the number of GAP-43 immunopositive axons was significantly greater than those in the PBS group. Neovascularization was observed only in the Doublet-1 group. We conclude that the combination of the three NFs was the most effective way to protect RGCs after the ONC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Meeting Abstract Ophthalmology

Decreased thickness of peripapillary retinal nerve fiber layer and ganglion cell complex in patients with Werner's syndrome

Hirotaka Yokouchi, Toshiyuki Oshitari

ACTA OPHTHALMOLOGICA (2021)

Article Biotechnology & Applied Microbiology

Effects of Switching from Anti-VEGF Treatment to Triamcinolone Acetonide in Eyes with Refractory Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion

Tomoaki Tatsumi, Toshiyuki Oshitari, Takayuki Baba, Yoko Takatsuna, Shuichi Yamamoto

BIOMED RESEARCH INTERNATIONAL (2020)

Article Endocrinology & Metabolism

Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol

Yuko Hayashi, Tomoaki Tatsumi, Toshiyuki Oshitari, Tomomi Kaiho, Yoko Takatsuna, Miyuki Arai, Takayuki Baba, Shuichi Yamamoto

Summary: The study compared the efficacy of one initial intravitreal injection of aflibercept followed by a pro re nata (PRN; 1+PRN) regimen to those of three consecutive monthly injections followed by the PRN (3+PRN) regimen for diabetic macular edema. The results showed that despite the 3+PRN regimen requiring more injections than the 1+PRN regimen, it led to better visual outcomes at 12 months.

JOURNAL OF DIABETES RESEARCH (2021)

Review Biochemistry & Molecular Biology

The Pathogenesis and Therapeutic Approaches of Diabetic Neuropathy in the Retina

Toshiyuki Oshitari

Summary: Diabetic retinopathy, a major retinal disease and top cause of blindness worldwide, involves neurovascular unit disturbances leading to neuronal and vascular abnormalities, particularly neuronal cell death and axon degeneration, directly impacting vision reduction in diabetic patients. Establishing neuroprotective and regenerative therapies for diabetic neuropathy in the retina is crucial in preventing blindness.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Ophthalmology

Ten-year epidemiological study of ocular and orbital tumors in Chiba University Hospital

Norihiro Shimizu, Toshiyuki Oshitari, Jiro Yotsukura, Hirotaka Yokouchi, Takayuki Baba, Shuichi Yamamoto

Summary: The study aimed to determine the epidemiology of tumors of the ocular adnexa and orbit in Japan. Malignant lymphoma was found to be the major malignant tumor in the study, and proactive pathological biopsies should be conducted to prevent missing IgG4-positive MALT lymphomas.

BMC OPHTHALMOLOGY (2021)

Editorial Material Cell Biology

Diabetic retinopathy: neurovascular disease requiring neuroprotective and regenerative therapies

Toshiyuki Oshitari

NEURAL REGENERATION RESEARCH (2022)

Article Biology

Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus

Tomoaki Tatsumi, Toshiyuki Oshitari, Yoko Takatsuna, Ryoichi Ishibashi, Masaya Koshizaka, Yuki Shiko, Takayuki Baba, Koutaro Yokote, Shuichi Yamamoto

Summary: This study found that systemic SGLT2i can reduce DMEs, suggesting that SGLT2i may be an additional treatment option to anti-VEGF treatments for eyes with DMEs.

LIFE-BASEL (2022)

Article Multidisciplinary Sciences

Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema

Tomoaki Tatsumi, Yoko Takatsuna, Toshiyuki Oshitari, Tomomi Kaiho, Yohei Kawasaki, Yuki Shiko, Takeshi Sugawara, Takayuki Baba, Shuichi Yamamoto

Summary: This study compared the efficacy and safety of intravitreal aflibercept combined with subthreshold laser therapy to intravitreal aflibercept monotherapy for treating diabetic macular edema. The results showed that the combination therapy did not reduce the number of injections needed and there was no significant difference in treatment outcomes between the two groups.

SCIENTIFIC REPORTS (2022)

Review Biochemistry & Molecular Biology

Advanced Glycation End-Products and Diabetic Neuropathy of the Retina

Toshiyuki Oshitari

Summary: Diabetic retinopathy is a tissue-specific neurovascular impairment in diabetic patients that affects the retina. Advanced glycation end-products (AGEs) are a major pathological factor causing neurovascular coupling impairments. Mechanisms such as AGE-receptor axis, reactive oxygen species, inflammation, and cell death pathways contribute to the impairment of neurovascular units. Neuronal cell death is directly associated with vision reduction in diabetic patients, highlighting the need for neuroprotective therapies targeting AGEs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Ophthalmology

Optical coherence tomography findings in three patients with Werner syndrome

Tatsuya Nagai, Hirotaka Yokouchi, Gen Miura, Masaya Koshizaka, Yoshiro Maezawa, Toshiyuki Oshitari, Koutaro Yokote, Takayuki Baba

Summary: This study documented three cases of Werner syndrome patients with thinning of the RNFL, GCC, and choroidal thickness observed using OCT. Visual field tests revealed visual field loss mainly due to glaucoma. These findings highlight the importance of considering Werner syndrome in the differential diagnosis for patients with juvenile cataracts of unknown cause showing abnormal retinal and choroidal thinning in the OCT images.

BMC OPHTHALMOLOGY (2022)

Review Biochemistry & Molecular Biology

Diabetic Neuropathy of the Retina and Inflammation: Perspectives

Guzel Bikbova, Toshiyuki Oshitari, Mukharram Bikbov

Summary: There is a clear connection between diabetes and atherosclerotic cardiovascular disease, necessitating therapeutic approaches that target both diseases. Ongoing clinical trials are examining the roles of obesity, adipose tissue, gut microbiota, and pancreatic beta cell function in diabetes. Inflammation plays a crucial role in diabetes pathophysiology and associated metabolic disorders, leading to increased interest in targeting inflammation for diabetes prevention and control. Diabetic retinopathy, a neurodegenerative and vascular disease that develops after poorly controlled diabetes, is also increasingly linked to inflammation. Molecular pathways such as oxidative stress and advanced glycation end-products contribute to the inflammatory response in diabetes-related complications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy

Toshiyuki Oshitari

Summary: Diabetic retinopathy (DR) is a common complication of diabetes and a prominent cause of blindness globally. Recently, DR has been defined as a neurovascular disease that impairs the retinal neurovascular function in individuals with diabetes. Neurovascular cell death is the primary cause of this impairment, and protecting neurovascular cells offers a potential therapy for preventing DR progression. Various cell death pathways, including apoptosis, necroptosis, ferroptosis, and pyroptosis, are associated with neurovascular cell death in DR, and targeting these regulated cell death mechanisms may serve as therapies to ameliorate DR pathogenesis. This review focuses on these cell death mechanisms and presents potential therapies that protect against neurovascular cell death in the treatment of DR.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Environmental Sciences

Neurovascular Impairment and Therapeutic Strategies in Diabetic Retinopathy

Toshiyuki Oshitari

Summary: This review focuses on the pathogenesis of neurovascular impairments in diabetic retinopathy and introduces possible neurovascular protective therapies.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Ophthalmology

Four Cases of Rhegmatogenous Retinal Detachment That Recurred More than 10 Years after Initial Reattachment by Pars Plana Vitrectomy

Takayuki Baba, Tomoaki Tatsumi, Toshiyuki Oshitari, Shuichi Yamamoto

Summary: This study reported 4 cases of recurrent rhegmatogenous retinal detachment 10-17 years after primary reattachment surgery by pars plana vitrectomy. The new retinal breaks were punched-out shaped without horseshoe tears or atrophic holes, and all cases achieved reattachment with combined vitrectomy and scleral buckling surgery. Best-corrected visual acuity ranged from 20/30 to 20/25 among patients.

CASE REPORTS IN OPHTHALMOLOGY (2021)

Review Ophthalmology

Understanding intrinsic survival and regenerative pathways through in vivo and in vitro studies: implications for optic nerve regeneration

Toshiyuki Oshitari

Summary: Adult neurons in the mammalian central nervous system do not regenerate after injury primarily due to reduced intrinsic regenerative pathways and inhibitory glial environment. Research focusing on optic nerve crush models has shed light on the basic knowledge and trends in CNS axonal regeneration. Expert suggest that stabilization of growth cones and multiple strategies are essential for successful optic nerve regeneration.

EXPERT REVIEW OF OPHTHALMOLOGY (2021)

暂无数据